Abstract
Patients with acute pancreatitis often suffer an uncontrolled superinflammation, and as a result of that a malfunctioning innate immune system, which frequently leads to complications: severe infections, systemic inflammatory syndrome, and sometimes multiple organ failure. Among the characteristics of the superinflammation are an exuberant, e.g., exaggerated and prolonged, inflammatory response, an aberrant cellular response, and extreme elevations in levels of cytokines and acute-phase proteins but also in levels of coagulation and growth factors. The cytokine storm, which occurs during the first few hours, will almost immediately reach the lungs and other distant organs via the lymphatics 1], and will condition them to be/make them susceptible to a subsequent infection. Overgrowth of potentially pathogenic microorganisms in the stomach and intestines, due to disease, inhibition of gastric and gastrointestinal (GI) secretions, and absence of a food stream, provides the source of bacteria for subsequent infection of the chest, pancreas, urinary tract, and other organs.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Deitch E. Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 2001;7:92–98
Sautner T, Függer R, Götzinger Pet al. Tumour necrosis factor-α and interleukin-6: Early indicators of bacterial infection after human orthotopic liver transplantation. Eur J Surg 1995;161: 97–101
Bengmark S. Bioecological control of perioperative and ITU morbidity. Langenbecks Arch Surg 2004;389:11–154
Bengmark S. Synbiotic control of inflammation and infection in transplantation. Transplant Rev 2004;18:38–53
Kompan L, Kremzar B, Gadzijev E, Prosek M. Effects of early enteral nutrition on intestinal permeability and the development of multiple organ failure after multiple injury. Intensive Care Med 1999;25:129–130
Roszkowski K, Ko KL, Beuth J, et al. Intestinal microflora of BALB/c-mice and function of local immune cells. Zeitschr Bakteriol Hygien 1988;270:270–279
Pulverer G, Ko HL, Roszkowski W, et al. Digestive tract microflora liberates low molecular weight peptides with immunotriggering activity. Zentralbl Bakteriol 1990;272:318–327
Isenmann R, Rünzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double blind trial. Gastroenterology 2004;126:997–1004
Engelich G, Wright DG, Hartshorn KL. Acquired disorders of phagocyte function complicating medical and surgical illnesses. Clin Infect Dis 2001;33:2040–2048
Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004;56:1058–1062
Deitch EA, Shorshtein A, Houghton J, Lu Q, Xu D. Inducible nitric oxide synthase knockout mice are resistant to diet-induced loss of gut barrier function and intestinal injury. J Gastrointest Surg 2002;6:599–605
Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A metaanalysis. J Trauma 2003;54: 908–914
Lai CWY, Barlow R, Barnes M, Hawthorne AB. Bedside placement of nasojejunal tubes: A randomized-controlled trial pf spirale- vs straight-ended tubes. Clin Nutr 2003;22:267–27
Bengmark S. Gut and the immune system: Enteral nutrition and immunonutrients. In Baue AE, Faist E, Fry D, eds. SIRS, MODS and MOF – Systemic Inflammatory Response Syndrome, Multiple Organ Dysfunction Syndrome, Multiple Organ Failure – Pathophysiology, Prevention and Therapy. Springer, New York, 2000, pp 420–436
Duncan C, Dougall H, Johnston P, et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrates. Nat Med 1995;1:546–551
Heyland D, Mandell LA. Gastric colonization by Gram-negative bacilli and nosocomial pneumonia in the intensive care unit patients. Chest 1992;101:187–193
Bengmark S. Use of pro-, pre- and synbiotics in the ICU – Future options. In Shikora SA, Martindale RG, Schwaitzberg SD, eds. Nutritional Considerations in the Intensive Care Unit – Science, Rationale and Practice. Kendall/Hunt, Dubuque, 2002, pp 381–399
Bengmark S. Aggressive peri- and intraoperative enteral nutrition – Strategy for the future. In Shikora SA, Martindale RG, Schwaitzberg SD, eds. Nutritional Considerations in the Intensive Care Unit – Science, Rationale and Practice. Kendall/Hunt, Dubuque, 2002, pp 365–380
McDonald WS, Sharp CW, Deitch EA. Immediate enteral feeding in burn patients is safe and effective. Ann Surg 1991;214:177–183
Rayner CK, Jones KL, Samsom N, Horowitz M. Relationship of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001;24:371–381
Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–1367
Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002;236:814–822
Du WD, Yuan ZR, Sun J, et al. Therapeutic efficacy of high dose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol 2003;11:2565–2569
Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002;22:283–307
Jain PK, McNaught CE, Anderson ADG, et al. Influence of synbiotic containing Lactobacillus acidophilus LA5, Bifidobacterium lactis BP12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomized controlled trial. Clin Nutr 2004;23:467–475
Bengmark S. Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients. Clin Nutr 2007;26:169–181
Riordan SM, Skinner N, Nagree A, et al. Peripheral blood mononuclear cell expression of Toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 2003;37:1154–1164
Qing Liu, Zhong Ping Duan, Da Kang Ha, et al. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatology 2004;39: 1441–1449.
Rayes N, Hansen S, Seehofer D, et al. Early enteral supply of Lactobacillus and fibre vs selective bowel decontamination (SBD) – A controlled trial in liver transplant recipients. Transplantation 2002;74:123–127
Rayes N, Seehofer D, Theruvath T, et al. Combined perioperative enteral supply of bioactive pre- and probiotics abolishes postoperative bacterial infections in human liver transplantation – a randomised, double blind clinical trial. Am J Transplant. 2005;5:125–130
Rayes N, Hansen S, Boucsein K, et al. Early enteral supply of fibre and lactobacilli vs parenteral nutrition – a controlled trial in major abdominal surgery patients. Nutrition 2002;18: 609–615
Han Chunmao, Huang H, Bengmark S. Pre- and postoperative enteral supply of a synbiotic composition – Synbiotic 2000 – reduces the incidence of postoperative septic complications in abdominal cancer surgery. Under publication
Spindler-Vesel A, Bengmark S, Kompan L. Glutamine, synbiotics, prebiotics or peptide in early enteral nutrition: A randomized study in trauma patients. JPEN 2007;31:119–126
Kotzampassi K, Giamerellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Benefits of Synbiotic 2000 Forte in critically ill trauma patients – early results of a randomized controlled trial. World J Surg 2006;30:1848–1855
Oláh A, Belágyi T, Issekutz Á, et al. Early enteral nutrition with specific lactobacillus and fibre reduces sepsis in severe acute pancreatitis. Br J Surg 2002;89:1103–1107
Oláh A, Belágyi T, Pótó L, Romics L Jr, Bengmark S. Synbiotic control of inflammation and infection in severe acute pancreatitis, a randomized double blind study. Hepato-Gastroenterology 2007;54:36–41
Rayes N, Seehofer D, Theruvath T, Mogl M, Wilke C, Schiller RA, Bengmark S, et al. Supply of pre- and probiotics reduces bacterial infection rates after pylorus-preserving pancreatoduodenectomy – a randomized, double-blind trial. Ann Surg 2007;246:36–41
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bengmark, S. (2009). Bioecological Control of Disease, Especially Pancreatic Disease. In: Iovanna, J., Ismailov, U. (eds) Pancreatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00152-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-00152-9_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00151-2
Online ISBN: 978-3-642-00152-9
eBook Packages: MedicineMedicine (R0)